Further studies are necessary to evaluate how nesfatin-1 and vaspin affect glucose metabolism in the early stages of GDM, and whether these adipokines can be adopted as its biomarkers in the first trimester of pregnancy, before the time when the OGTT is performed. This evidence concerns the gene SERPINA12 and gestational diabetes.